Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
10/2004
10/27/2004CN1539414A New medicinal preparation of sodium houttuynine sodium bisulfite and producing method
10/27/2004CN1172930C PDE IV inhibiting pyridine derivatives
10/27/2004CN1172929C Substituted indoles for modulating NFKB activity
10/27/2004CN1172714C Patent Chinese medicine for curing vascular headache
10/27/2004CN1172709C Medicine for treating rheumatalgia
10/27/2004CN1172697C Chinese adhesive plaster for curing rheumatism and hyperosteogeny
10/27/2004CN1172696C Medicine for preventing acute upper respiratory tract infection of children group
10/26/2004US6809204 Processes for the preparation of substituted isoxazoles and 2-isoxazolines
10/26/2004US6809199 (Halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents
10/26/2004US6809175 Cadherin derived growth factor and its use
10/26/2004US6809113 For therapy of arthritis, asthma, atherosclerosis, diabetic nephropathy, inflammatory bowel disease, crohn's disease, multiple sclerosis, nephritis, pancreatitis, pulmonary fibrosis, psoriasis, restenosis transplant rejection
10/26/2004US6809111 Antiinflammatory agents; analgesics
10/26/2004US6809100 Hydroxamic acid derivatives
10/26/2004US6809092 1,3,4,5-tetrahydro-2h-2-benzazepin-2-yl derivatives; cysteine protease inhibitors
10/26/2004US6809090 Nitrogen monoxide synthase and/or lipidic peroxidation inhibitors
10/26/2004US6809077 A cyclic polypeptides; immunosuppressive anti-inflammatory activity, inhibiting antigen-induced inflammatory cell infiltration
10/26/2004US6808710 Contacting cell expressing pd-1 with binding agent; genetic transduction of negative signal
10/26/2004CA2266759C 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase
10/26/2004CA2127214C New use of beta-naphtoquinone derivatives and of their salts for the production of a medicament which accelerate the growth of endothelial cells to inhibit no synthtases
10/26/2004CA2023811C Process and intermediates for preparing compounds having a disubstituted acetylene moiety and retinoic acid-like biological activity
10/21/2004WO2004089940A1 Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them
10/21/2004WO2004089929A1 5-amino-2-carbonylthiophene derivatives for use as p38 map kinase inhibitors in the treatment of inflammatory diseases
10/21/2004WO2004089927A1 Novel methods for the treatment of inflammatory diseases
10/21/2004WO2004089882A2 Aromatic sulfonamides as peroxynitrite-rearrangement catalysts
10/21/2004WO2004089881A1 New sulfonyl derivatives of aminonaphtols
10/21/2004WO2004089877A1 New hydroxynaphthyl amides
10/21/2004WO2004089876A1 Biphenylcarboxylic amide derivatives as p38 kinease inhibitors
10/21/2004WO2004089875A1 Biphenyl-carboxamide derivatives and their use as p38 kinase inhibitors
10/21/2004WO2004089874A1 Biphenyl carboxylic amide p38 kinase inhibitors
10/21/2004WO2004089427A1 Stable carprofen composition
10/21/2004WO2004089417A1 Drug-enclosing multilayer structure particulate and process for producing the same
10/21/2004WO2004089377A1 Calcium channel blockers comprising two benzhydril moieties
10/21/2004WO2004089341A1 Organic compounds
10/21/2004WO2004089292A2 Immunomodulatory agents for treatment of inflammatory diseases
10/21/2004WO2004089286A2 Novel compounds and compositions as protein kinase inhibitors
10/21/2004WO2004024728A3 Pyrazolo[3,4-b]pyridine compounds, and their use as phosphodiesterase inhibitors
10/21/2004WO2004009556A9 4-(substituted aryl)-5-hydroxyisoquinolinone derivative
10/21/2004WO2003062241A8 Fused heterocyclic succinimidecompounds and analogs thereof, modulators of nuclear hormone receptor function
10/21/2004WO2003045228A3 Methods for treating autoimmune disorders, and reagents related thereto
10/21/2004WO2003000014A3 Spherical protein particles and methods of making and using them
10/21/2004WO2002094210A3 Cosmetic agents
10/21/2004US20040210079 selective monoamine oxidase B inhibitors; neurodegenerative diseases; Alzheimer's Disease
10/21/2004US20040210052 Efficient synthesis of 5-heteroatom-containing-pyrazoles
10/21/2004US20040209959 X-Y, in which X is a benzyl group, a saturated or unsaturated cycloalkyl group or a non-cyclic, straight or branched alkyl group, optionally in combination with another analgesic, such as an NSAID or an opioid.
10/21/2004US20040209956 S-[2-[(1-Iminoethyl)amino]ethyl]-2-methyl-L-cysteine maleate form II crystalline salt
10/21/2004US20040209948 especially naphthalene sulfonamides, used for treating asthma
10/21/2004US20040209938 Novel 1,3-dihydro-2H-indol-2one derivatives, process for preparing them and pharmaceutical compositions containing them
10/21/2004US20040209935 Pyrazole-derived kinase inhibitors and uses thereof
10/21/2004US20040209922 Pyridine matrix metalloproteinase inhibitors
10/21/2004US20040209914 Aromatic sulfone hydroxamic acids and their use as protease inhibitors
10/21/2004US20040209913 Bicyclic Heteroaromatic Alanines
10/21/2004US20040209908 New derivatives of hydantoins, thiohydantoins, pyrimidinediones and thioxopyrimidinones, their preparation processes and their use as medicaments
10/21/2004US20040209901 substituted 2,4,8-trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compounds, e.g., 8-(2,6-Difluoro-phenyl)-4-(4-fluoro-2-methyl-phenyl)-2-(2-hydroxy-1-hydroxymethyl-ethylamino)-8H-pyrido[2,3-d]pyrimidin-7-one; CSBP/p38 kinase inhibitors.
10/21/2004US20040209894 e.g., 1-(4-chloroanilino)-4-[2-(pyridin-3-yl)-ethyl]-isoquinoline and 5-[4-(tert-butyl)-anilino]-8-[(6-methoxy-pyridin-3-yl)-methyl]-[1,6]naphthyridine
10/21/2004US20040209893 treatment of a condition mediated by a tachykinin including substance P and other neurokinins by administering N-benzyl-2-phenylpiperazine-1-carboxamides, e.g., 2-(4-Fluoro-2-methyl-phenyl)-piperazine-1-carboxylic Acid (3,5-bistrifuoromethyl-benzyl)-methyl-amide Hydrochloride .
10/21/2004US20040209889 N-substituted nonaryl-heterocyclic nmda/nr2b antagonists
10/21/2004US20040209879 Piperidinyl derivates as modulators of chemokine receptor activity
10/21/2004US20040209874 Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-alpha converting enzyme (TACE)
10/21/2004US20040209872 Calcium channel blockers comprising two benzhydril moieties
10/21/2004US20040209868 Substituted indoles
10/21/2004US20040209843 addtion of a cyclodextrin compound increases the water solubility; storage stable solution; immediately treating symptoms of acute phases of myocardial or a cerebral infarction
10/21/2004US20040209822 Novel compounds
10/21/2004US20040209813 Caspase inhibitors for inhibiting blood cell proliferation and for treating autoimmune diseases
10/21/2004US20040209805 such as fibrosis via activin antagonist (fullistatin); kits; gene therapy; treating inflammatory bowel disease and crohn's disease
10/21/2004US20040209799 comprises inhibitors (cytokines) of janus kinases (JAK)/signal transducers and activators of transcription (STAT) other than debromohymenialdisine and hymensialdisine; gene expression inhibition; bioassay, immunoassay, drug screening; for treatment of degenerative joint diseases such as osteoarthritis
10/21/2004US20040208944 Compositions and methods against inflammatory processes
10/21/2004US20040208941 Compositions for removal of toxins
10/21/2004US20040208924 active pharmaceutical ingredient is for example [(2S)-Sulfanyl-5-[(N,N-dimethylamino)acetyl]aminopentanoyl-L-leucyl-L-tert-leucine N-methylamide; bonding strength, stability
10/21/2004US20040208844 Products and drug delivery vehicles
10/21/2004DE102004016947A1 Feste pharmazeutische Zusammensetzung A solid pharmaceutical composition
10/21/2004CA2707750A1 Solid pharmaceutical compositions comprising a s1p receptor agonist and a sugar alcohol
10/21/2004CA2522023A1 Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them
10/21/2004CA2521875A1 Calcium channel blockers comprising two benzhydril moieties
10/21/2004CA2521653A1 Aromatic sulfonamides as peroxynitrite-rearrangement catalysts
10/21/2004CA2521606A1 Novel methods for the treatment of inflammatory diseases
10/21/2004CA2521603A1 Stable carprofen composition
10/21/2004CA2521228A1 Biphenyl carboxylic amide p38 kinase inhibitors
10/21/2004CA2521184A1 Novel compounds and compositions as protein kinase inhibitors
10/20/2004EP1469316A1 Screening method
10/20/2004EP1469084A2 Polymorphisms in the human KDR gene
10/20/2004EP1469009A2 Compositions and methods for non-parenteral delivery of oligonucleotides
10/20/2004EP1469000A1 Novel crystalline tricyclic triazolobenzazepine derivative
10/20/2004EP1468991A1 Imides as PDE III, PDE IV and TNF inhibitors
10/20/2004EP1468989A2 Compounds and methods for the inhibition of the expression of VCAM-1
10/20/2004EP1468695A1 Methods and compositions useful for inhibition of angiogenesis
10/20/2004EP1468679A2 Controlled release formulation containing tramadol
10/20/2004EP1468097A2 METHODS OF GENERATING MULTISPECIFIC, MULTIVALENT AGENTS FROM V sb H /sb AND V sb L /sb DOMAINS
10/20/2004EP1468091A2 Transmembrane protein
10/20/2004EP1468020A2 Multimers of receptor-binding ligands
10/20/2004EP1468019A2 Secreted protein
10/20/2004EP1468018A2 Leptin proteins
10/20/2004EP1468008A2 MACROPHAGE MIGRATION INHIBITORY FACTOR (MIF) PROMOTER POLYMORPHISM IN INFLAMMATORY DISEASE
10/20/2004EP1467997A1 Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with cyclic amino group
10/20/2004EP1467995A2 Pyrrolopyrimidine a2b selective antagonist compounds, their synthesis and use
10/20/2004EP1467994A1 Pteridine derivatives, method for the production thereof, and use thereof
10/20/2004EP1467982A1 Glucocorticoid mimetics, methods of making them, pharmaceutical formulations containing them, and uses thereof
10/20/2004EP1467976A1 N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases
10/20/2004EP1467972A1 Indazole compounds useful as protein kinase inhibitors
10/20/2004EP1467968A1 N-(4-substituted phenyl)-anthranilic acid hydroxamate esters
10/20/2004EP1467965A1 N-(4-substituted phenyl)-anthranilic acid hydroxamate esters
1 ... 710 711 712 713 714 715 716 717 718 719 720 721 722 723 724 725 726 727 728 729 730 ... 1272